Gracie McGraw, the daughter of renowned country singers Tim McGraw and Faith Hill, recently defended her decision to take Ozempic, a medication known for its weight loss effects, in the face of criticism. McGraw, known for her online presence, took to Instagram on May 26 to share a couple of photos and was met with a comment about Ozempic. Seizing the opportunity to address the issue, McGraw responded to the commenter, explaining her current situation and clarifying her use of the medication.
Confirming that she did indeed take Ozempic in the past, McGraw shared that she has now switched to a low dose of Mounjaro to manage her polycystic ovary syndrome (PCOS). She emphasized that there was no need for accusations, as she has been open about her journey and the medications she has used to address her health concerns. It’s crucial to note that Mounjaro, like Ozempic, is FDA-approved for treating Type 2 diabetes and can also promote weight loss. Eli Lilly, the manufacturer of Mounjaro, has stressed that it does not endorse off-label use of their medications.
In a previous social media post in March 2022, McGraw shared her PCOS diagnosis and discussed her experience with Ozempic. The medication had a transformative effect on her body, and she expressed her newfound appreciation for herself and the changes she has observed. PCOS can cause hormonal imbalances and metabolic challenges, leading to weight gain or difficulties in losing weight, as per the Office on Women’s Health.
TODAY.com also featured the story of Wynter Mitchell, a woman in her 40s who, like McGraw, used Ozempic to manage her weight as part of her journey towards successful in vitro fertilization. Mitchell experienced significant weight loss within just a month of taking the medication and expressed her excitement over the progress. However, maternal-fetal medicine specialists have urged for further research on the impact of these medications on women of childbearing age.
Novo Nordisk, the manufacturer of Ozempic, has emphasized that their medication should only be used for its FDA-approved purpose and does not support off-label use. The company trusts that healthcare providers evaluate individual patient needs and prescribe suitable treatments accordingly.
Gracie McGraw’s response to the criticism surrounding her use of Ozempic showcases her confidence and determination to address her healthcare concerns openly. By sharing her story, she aims to create awareness and understanding around PCOS and the use of medications like Ozempic for managing related symptoms, emphasizing the importance of appropriate medical guidance and individualized care.
